Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

CASI Stock Annual Income Statement. Download in Excel

CASI Pharmaceuticals Inc. logo

CASI Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Biotechnology

2.65
 
USD
  
-0.04
  
(-1.49%)
Previous close: 2.69  Open: 2.72  Bid: 2.78  Ask: 3.9
52 week range    
2.05   
   8.19
Mkt Cap: 47 M  Avg Vol (90 Days): 107,712
Peers   
RGEN / 
CRIS / 
NBIX / 
AMGN / 
CYCC / 
BTX / 
SGEN / 
FRX-CA / 
Last updated: Monday 23rd December 2024

Stock Rankings

43
MarketXLS Rank
60
Value
15
Technical
55
Quality
How are these ranks calculated?
Search for a stock

Financials

CASI Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
AllowancesForConstruction-11764.0
Amortization of intangibles-1 M-2 M1 M12 M1 M
Basic EPS from continuing operations-44.0-27.0-3.01-2.02
Basic EPS total-44.0-2.69-3.01-2.02
Basic weighted shares outstanding3 M3 M6 M6 M8 M959480.01 M1 M14 M13 M
Cost of sales-7467.0-6274.04 M10 M13 M16 M14 M
Depletion-27513.0
Depreciation-48179.0-68381.0-66451.0-117779.0-366000.0-603000.0562000.0500000.01 M
Depreciation unreconciled-27513.06788.019891.0
DepreciationAndAmortization-48179.0-68381.0-66451.0-117779.0-366000.0-603000.0562000.0500000.01 M
Diluted EPS total-9.2-2.2-1.7-1.8-3.2-48.0-44.0-27.0-3.01-2.02
Diluted normalized net income/share-48.0-27.0-3.01-2.02
Diluted weighted shares outstanding3 M3 M6 M6 M9 M959.01104.01 M14 M13 M
Earnings from equity interest4 M566000.0
EarningsFromEquityInterestNetOfTax4 M566000.0
Fees-320112.0
GainOnSaleOfPPE-400000.0-65000.0-2 M
GainOnSaleOfSecurity-865000.020000.0
GeneralAndAdministrativeExpense4 M3 M5 M3 M18 M27 M20 M24 M23 M25 M
Gross operating profit16260.041438.0-687000.0128000.06 M18 M27 M20 M
ImpairmentOfCapitalAssets-386000.02 M9 M2 M
Income before tax-26 M-7 M-9 M-11 M-27 M-46 M-48 M-36 M-38 M-26 M
Income taxes-681000.0-837000.06788.0-125000.0-732000.02 M-81000.0
InterestExpenseNonOperating-7500.0-7500.03000.0-866000.0-321000.0-127000.0
MarketingExpense-27513.0
MinorityInterests395000.0-776000.0-812000.09 M-679000.0
MiscOtherSpecialCharges73000.01 M558000.044000.0764000.0
Net income from total operations-26 M-7 M-9 M-11 M-27 M-46 M-48 M-37 M-41 M-27 M
NetIncomeCommonStockholders-26 M-7 M-9 M-11 M-27 M-46 M-48 M-37 M-41 M-27 M
NetIncomeContinuousOperations-26 M-7 M-9 M-11 M-27 M-46 M-48 M-37 M-41 M-26 M
NetIncomeFromOtherGainsLosses2 M2 M9 M
NetNonOperatingInterestIncomeExpense7500.07500.0-3000.0866000.0321000.0127000.0-614000.0
NetOperatingInterestIncomeExpense-26581.0-81533.0-26090.01009.040000.0
Normalized income-30 M-25 M-24 M
Operating income-26 M-7 M-9 M-11 M-28 M-47 M-52 M-42 M-26 M-25 M
Operating income before depreciation (EBITDA)-26 M-7 M-9 M-11 M-26 M-44 M-31 M-33 M-35 M-21 M
OperatingExpense26 M7 M9 M11 M27 M47 M57 M59 M54 M45 M
Other income net-11764.0615000.0-6 M-5 M6 M-2 M
Other special charges288000.0
OtherCostofRevenue14 M
OtherGandA4 M3 M5 M3 M18 M27 M20 M24 M23 M25 M
OtherImpairmentOfCapitalAssets-306000.0-1 M-6 M
OtherOperatingExpenses-34000.0-34000.0-35000.0-62000.0-2000.0-1 M
OtherTaxes-11764.0
RentAndLandingFees4 M3 M5 M3 M18 M
Research & development expense22 M4 M5 M8 M9 M16 M29 M21 M16 M10 M
ResearchExpense22 M4 M5 M8 M9 M16 M29 M21 M16 M10 M
Revenue per share-26000.0-75000.0-26000.0-7000.0-1 M-2 M1 M12 M1 M
SalariesAndWages-2 M-2 M-3 M-650440.0320000.0-7 M8 M8 M7 M
SecuritiesAmortization1 M
Selling Gen & administrative expense4 M3 M5 M3 M18 M30 M27 M38 M38 M42 M
SellingAndMarketingExpense-27513.03 M8 M15 M14 M16 M
SellingExpense3 M
Special income/charges386000.0-2 M-9 M-2 M
Total Income available for interest expense (EBIT)-26 M-7 M-9 M-11 M-27 M-46 M-33 M-35 M-38 M-26 M
Total common shares outstanding324458.0425833.0601965.0796418.0957170.0990237.01 M1 M13 M
Total net income-26 M-7 M-9 M-11 M-27 M-46 M-48 M-37 M-41 M-27 M
Total ordinary shares15 M15 M15 M15 M15 M15 M15 M15 M15 M15 M
Total revenues23727.047712.04 M15 M30 M43 M40 M
TotalExpenses26 M7 M9 M11 M27 M51 M66 M72 M70 M59 M
TotalRevenue23727.047712.04 M15 M30 M43 M34 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University